Pharmaceutical preparations for the treatment of psychiatric and neurodegenerative diseases and disorders including schizophrenia, depression, major depressive disorder, stress, anxiety, treatment resistant depression, bipolar depression, bipolar disorder; pharmaceutical preparations for the mitigation of weight gain and the treatment of metabolic diseases and dyslipidemia

'anxieti':20 'bipolar':24,26 'depress':15,17,23,25 'diseas':10,41 'disord':12,18,27 'dyslipidemia':43 'gain':35 'includ':13 'major':16 'metabol':40 'mitig':32 'neurodegen':9 'pharmaceut':1,28 'prepar':2,29 'psychiatr':7 'resist':22 'schizophrenia':14 'stress':19 'treatment':5,21,38 'weight':34

NUQLARIS

Owners

Goods & Services